Liquid Biopsy Market Outlook


Liquid Biopsy Market is projected to exceed US$ 3.4 Billion by the year 2024. Renub Research report titled “Liquid Biopsy Market, by Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer & Others), Product (Kits & Consumables, Instruments and Services), Circulating Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) & Exosomes), Sample (Plasma/Serum, Urine & Others), Clinical Application (Monitoring, Prognosis, Theranostics & Screening), Regions (North America, Europe, Asia-Pacific, Latin America and Middle East/Africa), Companies (Thermo Fisher Scientific Inc., Roche Diagnostics, Bio-Rad Laboratories Inc., Biocept Inc., Biocartis, Myriad Genetics Inc., Genomic Health, NeoGenomics Laboratories, Qiagen)” provides a complete analysis of Global Liquid Biopsy Market.

Read »

Created by renubresearch 15 weeks 2 days ago – Made popular 15 weeks 1 day ago
Category: Health   Tags:

BTC:  1BXApkUERv985SFnXrtrSxNSbm7qxhiHa5
LTC:   LbaPFdG5uaKe7bGQXcK5LAGFBKbfjT8sWp
ETH:  0xDfA4Bd2946C39907A9F82bd54a32d098678858dC
DASH:  XiaBkiG8GHt9PgXuGPfzg5MdAkZtiUz89H
DCR:  DsW4vSP5M5cx7TMWNCcgrUZb3w2kr4VUxY6

User login

EzySpot is a news/social bookmarking site.

Monetize Your Website


Syndicate content